Get the Stockscreener App
1.10
3.77%
0.04
After Hours:
1.10
Sonoma Pharmaceuticals Inc stock is traded at $1.10, with a volume of 107.38K.
It is up +3.77% in the last 24 hours and down -46.34% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$1.06
Open:
$1.1
24h Volume:
107.38K
Relative Volume:
0.64
Market Cap:
$3.82M
Revenue:
$17.72M
Net Income/Loss:
$-3.37M
P/E Ratio:
-0.5397
EPS:
-2.038
Net Cash Flow:
$-3.72M
1W Performance:
+0.92%
1M Performance:
-46.34%
6M Performance:
-65.62%
1Y Performance:
-66.87%
1-Day Range:
$1.07
$1.11
1-Week Range:
$1.00
$1.13
52-Week Range:
$0.8501
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
1.10 | 3.68M | 17.72M | -3.37M | -3.72M | -2.038 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Sonoma Pharmaceuticals (SNOA) Edges Higher, Testing Key Resistance at $1.13Volatility Smirk - Newser
SNOA SEC FilingsSonoma Pharmaceu 10-K, 10-Q, 8-K Forms - Stock Titan
Sonoma Pharmaceuticals (SNOA) Slips -3.56%, Testing $1.08 Support 2026-05-15Fast Rising Stocks - Newser
Sonoma Pharmaceuticals (SNOA) Q1 2026 Earnings Miss by Significant: Key TakeawaysRevenue Guidance Update - Newser
SNOA Director Jacoby Vanessa Stock Option Filing, May 14, 2026 - Meyka
Sonoma Pharmaceuticals (SNOA) outlines plan to reincorporate from Delaware to Nevada - Stock Titan
Sonoma Pharmaceuticals Completes Equity Offering to Raise Capital - The Globe and Mail
Sonoma Pharmaceuticals Prices $1.35 Unit Offering, Nets ~$3.5M Under Underwriting With Dawson James - TradingView
Sonoma Pharmaceuticals (NASDAQ: SNOA) closes $4M stock and warrant sale - Stock Titan
SNOA Sonoma Pharmaceuticals reports narrow Q1 2026 EPS miss as shares rise 1.92 percent on mild positive investor sentiment.Cost Advantage - Newser
SNOA Director Jacoby Vanessa Stock Option Filing, April 28, 2026 - Meyka
Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law - MSN
What's Going On With Sonoma Pharma Stock Monday? - Benzinga
2.96M-unit offering priced at $1.35 — Sonoma Pharmaceuticals (NASDAQ: SNOA) - Stock Titan
SNOA Drops As Sonoma Pharmaceuticals Launches Dilutive Offering - StocksToTrade
Sonoma Pharmaceuticals (SNOA) Secures $4M in Public Offering - GuruFocus
Sonoma Pharmaceuticals prices $4M stock offering at $1.35 per share - Investing.com
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering - ACCESS Newswire
[EFFECT] Sonoma Pharmaceuticals, Inc. SEC Filing - Stock Titan
Sonoma Pharmaceuticals (NASDAQ: SNOA) files S-1 for $5M unit and warrant sale - Stock Titan
SNOA (Sonoma Pharmaceuticals Inc.) Q1 2026 revenue growth drives 2.75 percent share gain despite narrow EPS miss.ROE - UBND thành phố Hải Phòng
SNOA Sonoma Pharmaceuticals shares jump 15 percent on 12 percent Q1 2026 revenue growth despite minor EPS miss.Crowd Entry Points - newser.com
According to the latest filing from the U.S. Securities and Exchange Commission (SEC), Sonoma Pharmaceuticals, Inc. announced the launch of a public offering, aiming to raise a total of $5 million through the issuance of units. - Exchange Bitget
Sonoma Pharmaceuticals IncOffers Units In Public Offering For Gross Proceeds Of $5 MillionSEC Filing - TradingView
Sonoma Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933 - Moomoo
Sonoma Pharmaceuticals (NASDAQ: SNOA) plans $5M stock and warrant sale - Stock Titan
Will Sonoma Pharmaceuticals Inc stock go up in YEARQuarterly Portfolio Report & Risk Adjusted Swing Trade Ideas - baoquankhu1.vn
US Stocks Recap: Can Sonoma Pharmaceuticals Inc expand into new marketsWeekly Trade Report & Safe Capital Growth Tips - baoquankhu1.vn
3 Biotech Stocks Surge with Momentum - National Today
Sonoma Pharmaceuticals and Kenvue Brands Sign Manufacturing and Supply Agreement for Microcyn® Technology Products Through 2027 - Minichart
Sonoma Pharmaceuticals enters manufacturing agreement with Kenvue Brands - Investing.com
Sonoma Pharmaceuticals Enters U.S. Manufacturing and Supply Pact With Kenvue for Microcyn Line - TradingView — Track All Markets
Sonoma Pharmaceuticals (SNOA) signs Kenvue U.S. Microcyn manufacturing and supply deal - Stock Titan
Sonoma Pharmaceuticals, Inc. Enters Manufacturing And Supply Agreement With Kenvue Brands LLC - marketscreener.com
Breakout Move: Is Sonoma Pharmaceuticals Inc currently under institutional pressure2026 Intraday Action & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Is Sonoma Pharmaceuticals (SNOA) Stock Worth Holding | Price at $2.33, Down 1.90%Low Volatility Stocks - Newser
Aug Opening: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin - The Patriot Ledger
Sonoma Pharmaceuticals (SNOA) jumps 16% after hours on burn relief hydrogel launch in Walmart, CVS - msn.com
Sonoma Pharmaceuticals (SNOA) Jumps 16% After Hours On Burn Relief Hydrogel Launch In Walmart, CVS - Benzinga
Market Wrap: How correlated is Sonoma Pharmaceuticals Inc to the S P5002026 Sector Review & Fast Moving Trade Plans - baoquankhu1.vn
Published on: 2026-03-26 16:02:54 - baoquankhu1.vn
Sonoma Pharmaceuticals Launches Advanced Burn Relief Hydrogel in Walmart and CVS Stores Nationwide - AD HOC NEWS
CVS Now Stocking Sonoma Pharmaceuticals' HOCl-Based Burn Relief Hydrogel - gurufocus.com
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart - Bitget
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart - Investing.com
Sonoma Pharmaceuticals launches burn relief gel at CVS, Walmart By Investing.com - Investing.com UK
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):